Assessing effectiveness in acne clinical trials: steps towards a core outcome measure set

被引:10
作者
Thiboutot, D. M. [1 ]
Layton, A. M. [2 ]
Chren, M. -M. [3 ]
Eady, E. A. [2 ]
Tan, J. [4 ]
机构
[1] Penn State Univ, Dept Dermatol, 500 Univ Dr, Hershey, PA 17033 USA
[2] Harrogate & Dist NHS Fdn Trust, Dept Dermatol, Harrogate, England
[3] Vanderbilt Univ, Dept Dermatol, 221 Kirkland Hall, Nashville, TN 37235 USA
[4] Western Univ, Schulich Sch Med & Dent, Windsor, ON, Canada
基金
美国国家卫生研究院;
关键词
QUALITY-OF-LIFE; INTERNATIONAL DERMATOLOGY; FACIAL ACNE; VALIDATION; RELIABILITY; INDEX; INSTRUMENT; COMPONENTS; SEVERITY; FEATURES;
D O I
10.1111/bjd.18011
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Acne ranks second to dermatitis in terms of global burden of skin disease. As such, it is essential that data on treatment efficacy are generated in a way that maximizes the opportunity for comparison among treatments. Interest in developing core outcome sets for use in clinical trials to standardize data collection in skin disease is surging. Objectives The goal of this review is to provide an update on the efforts underway, challenges encountered and future directions in the development of an acne core outcome measure set for use in clinical trials. Methods The activities of the Acne Core Outcomes Research Network (ACORN) are presented in the context of currently acceptable methodologies for core outcome set development. Conclusions Emphasis is placed on following a rigorous methodology, involving patients and recognizing a role for emerging technologies.
引用
收藏
页码:700 / 706
页数:7
相关论文
共 44 条
[1]  
Agnew Tamara, 2016, J Clin Aesthet Dermatol, V9, P40
[2]  
Alexis A, 2014, J DRUGS DERMATOL, V13, P333
[3]   Development and validation of a quality of life instrument for cutaneous diseases [J].
Anderson, RT ;
Rajagopalan, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (01) :41-50
[4]   Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 [J].
Boers, Maarten ;
Kirwan, John R. ;
Wells, George ;
Beaton, Dorcas ;
Gossec, Laure ;
d'Agostino, Maria-Antonietta ;
Conaghan, Philip G. ;
Bingham, Clifton O., III ;
Brooks, Peter ;
Landewe, Robert ;
March, Lyn ;
Simon, Lee S. ;
Singh, Jasvinder A. ;
Strand, Vibeke ;
Tugwell, Peter .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (07) :745-753
[5]   Quality of life measurement in acne. Position Paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa [J].
Chernyshov, P. V. ;
Zouboulis, C. C. ;
Tomas-Aragones, L. ;
Jemec, G. B. ;
Manolache, L. ;
Tzellos, T. ;
Sampogna, F. ;
Evers, A. W. M. ;
Dessinioti, C. ;
Marron, S. E. ;
Bettoli, V. ;
van Cranenburgh, O. D. ;
Svensson, A. ;
Liakou, A. I. ;
Poot, F. ;
Szepietowski, J. C. ;
Salek, M. S. ;
Finlay, A. Y. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (02) :194-208
[6]   The Skindex Instruments to Measure the Effects of Skin Disease on Quality of Life [J].
Chren, Mary-Margaret .
DERMATOLOGIC CLINICS, 2012, 30 (02) :231-+
[7]   Acne Scars: How Do We Grade Them? [J].
Clark, Ashley K. ;
Saric, Suzana ;
Sivamani, Raja K. .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (02) :139-144
[8]  
Elman SA, 2017, J DRUGS DERMATOL, V16, P119
[9]   Evaluating health-related quality of life in patients with facial acne: Development of a self-administered questionnaire for clinical trials [J].
Girman, CJ ;
Hartmaier, S ;
Thiboutot, D ;
Johnson, J ;
Barber, B ;
DeMuroMercon, C ;
Waldstreicher, J .
QUALITY OF LIFE RESEARCH, 1996, 5 (05) :481-490
[10]  
Gold LS, 2016, J DRUGS DERMATOL, V15, P79